Trial Profile
Study evaluating the prevalence and predictors of high-on treatment platelet reactivity after treatment with ticagrelor in patients with acute coronary syndroms who are undergoing stem implantation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Acute coronary syndromes
- Focus Pharmacodynamics
- 21 Dec 2016 New trial record